| |
|
|
| Name: |
Opaleye Management Inc. |
| City: |
Cambridge |
| State: |
MA |
| Zip: |
02140 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
10 |
|
View All Holdings |
Currently
Viewing:
New Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
ARVN |
Arvinas Holding Company, Llc |
11 |
New |
$32.82 |
$10,854,000 |
263,700 |
2.91% |
10,854,000 |
263,700 |
0.496 |
N/A |
|
|
ARQT |
Arcutis Biotherapeutics, Inc. |
16 |
New |
$8.00 |
$6,331,000 |
1,960,000 |
1.7% |
6,331,000 |
1,960,000 |
2.61 |
N/A |
|
|
JSPR |
Jasper Therapeutics Ord Shs |
28 |
New |
$15.12 |
$3,144,000 |
3,985,340 |
0.84% |
3,144,000 |
3,985,340 |
3.923 |
N/A |
|
|
NAMS |
Newamsterdam Pharma Ord Shs |
30 |
New |
$0.00 |
$2,964,000 |
265,388 |
0.79% |
2,964,000 |
265,388 |
0.325 |
N/A |
|
|
VTYX |
Ventyx Biosciences, Inc. |
32 |
New |
$4.85 |
$2,816,000 |
1,140,000 |
0.75% |
2,816,000 |
1,140,000 |
2.267 |
N/A |
|
|
SYRS |
Syros Pharmaceuticals, Inc. |
33 |
New |
$5.13 |
$2,799,000 |
359,370 |
0.75% |
2,799,000 |
359,370 |
0.639 |
N/A |
|
|
PTGX |
Protagonist Therapeutics, Inc |
35 |
New |
$26.09 |
$2,584,000 |
112,700 |
0.69% |
2,584,000 |
112,700 |
0.2 |
N/A |
|
|
CNTX |
Context Therapeutics Inc. |
42 |
New |
$0.00 |
$1,102,000 |
975,000 |
0.3% |
1,102,000 |
975,000 |
6.109 |
N/A |
|
|
ALGS |
Aligos Therapeutics, Inc. |
44 |
New |
$0.00 |
$861,000 |
1,297,000 |
0.23% |
861,000 |
1,297,000 |
3.703 |
N/A |
|
|
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
45 |
New |
$20.08 |
$640,000 |
37,500 |
0.17% |
640,000 |
37,500 |
0.111 |
N/A |
|
